Inhibition of KIF14 Suppresses Tumor Cell Growth and Promotes Apoptosis in Human Glioblastoma

Cellular Physiology and Biochemistry

Volumn 37, Issue 5, 2015, Pages 1659-1670

  Huang, Wei ^a,b   Wang, Junyu ^b   Zhang, Danfeng ^b   Chen, Wen ^b   Hou, Lijun ^b   Wu, Xiaojun ^b   Lu, Yicheng ^b  

^a KUNMING GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Apoptosis; Astrocytoma; Cell cycle; KIF14

Indexed keywords

KI 67 ANTIGEN; KINESIN SUPERFAMILY PROTEIN 14; MOLECULAR MOTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; KIF14 PROTEIN, HUMAN; KINESIN; ONCOPROTEIN; PROTEIN KINASE B;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINESIS; DIFFUSE ASTROCYTOMA; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; M PHASE CELL CYCLE CHECKPOINT; MOUSE; NONHUMAN; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; AGED; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN TUMOR; CELL PROLIFERATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE; UPREGULATION;

AGED; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; KINESIN; M PHASE CELL CYCLE CHECKPOINTS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84948170763     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438532     Document Type: Article

References (34)

1. Taylor LP: Diagnosis, treatment, and prognosis of glioma: five new things. Neurology 2010;75:S28-32.
2. Dunbar E, Yachnis AT: Glioma diagnosis: immunohistochemistry and beyond. Adv Anat Pathol 2010;17:187-201.
3. Rulseh AM, Keller J, Klener J, Sroubek J, Dbaly V, Syrucek M, Tovarys F, Vymazal J: Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields. World J Surg Oncol 2012;10:220.
4. Henriksson R, Asklund T, Poulsen HS: Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. J Neurooncol 2011;104:639-646.
5. Hadjipanayis CG, Van Meir EG: Brain cancer propagating cells: biology, genetics and targeted therapies. Trends Mol Med 2009;15:519-530.
6. Hadjipanayis CG, Van Meir EG: Tumor initiating cells in malignant gliomas: biology and implications for therapy. J Mol Med (Berl) 2009;87:363-374.
7. Hirokawa N, Tanaka Y: Kinesin superfamily proteins (KIFs): Various functions and their relevance for important phenomena in life and diseases. Exp Cell Res 2015;334:16-25.
8. Hung PF, Hong TM, Hsu YC, Chen HY, Chang YL, Wu CT, Chang GC, Jou YS, Pan SH, Yang PC: The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinoma. PLoS One 2013;8:e61664.
9. Miki H, Okada Y, Hirokawa N: Analysis of the kinesin superfamily: insights into structure and function. Trends Cell Biol 2005;15:467-476.
10. Carleton M, Mao M, Biery M, Warrener P, Kim S, Buser C, Marshall CG, Fernandes C, Annis J, Linsley PS: RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure. Mol Cell Biol 2006;26:3853-3863.
11. Molina I, Baars S, Brill JA, Hales KG, Fuller MT, Ripoll P: A chromatin-associated kinesin-related protein required for normal mitotic chromosome segregation in Drosophila. J Cell Biol 1997;139:1361-1371.
12. Gruneberg U, Neef R, Li X, Chan EH, Chalamalasetty RB, Nigg EA, Barr FA: KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol 2006;172:363-372.
13. Ohkura H, Torok T, Tick G, Hoheisel J, Kiss I, Glover DM: Mutation of a gene for a Drosophila kinesin-like protein, Klp38B, leads to failure of cytokinesis. J Cell Sci 1997;110:945-954.
14. Xu H, Choe C, Shin SH, Park SW, Kim HS, Jung SH, Yim SH, Kim TM, Chung YJ: Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Exp Mol Med 2014;46:e97.
15. Markowski J, Oczko-Wojciechowska M, Gierek T, Jarzab M, Paluch J, Kowalska M, Wygoda Z, Pfeifer A, Tyszkiewicz T, Jarzab B, Niedzielska I, Borgiel-Marek H: Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol 2009;60:57-63.
16. Singel SM, Cornelius C, Batten K, Fasciani G, Wright WE, Lum L, Shay JW: A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res 2013;19:2061-2070.
17. Theriault BL, Cybulska P, Shaw PA, Gallie BL, Bernardini MQ: The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells. J Ovarian Res 2014;7:123.
18. Wang Q, Wang L, Li D, Deng J, Zhao Z, He S, Zhang Y, Tu Y: Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol 2013;37:79-84.
19. Ding D, Wei S, Song Y, Li L, Du G, Zhan H, Cao Y: Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways. Cell Physiol Biochem 2013;32:1751-1760.
20. Liu E, Kuang Y, He W, Xing X, Gu J: Casticin induces human glioma cell death through apoptosis and mitotic arrest. Cell Physiol Biochem 2013;31:805-814.
21. Yuan Q, Gao W, Liu B, Ye W: Upregulation of miR-184 enhances the malignant biological behavior of human glioma cell line A172 by targeting FIH-1. Cell Physiol Biochem 2014;34:1125-1136.
22. Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ: Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res 1986;46:4109-4115.
23. Tomayko MM, Reynolds CP: Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989;24:148-154.
24. Arora K, Talje L, Asenjo AB, Andersen P, Atchia K, Joshi M, Sosa H, Allingham JS, Kwok BH: KIF14 binds tightly to microtubules and adopts a rigor-like conformation. J Mol Biol 2014;426:2997-3015.
25. Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, Seki N, Kawarabayasi Y, Ishikawa K, Tabata S: Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1 (supplement). DNA Res 1994;1:251-262.
26. Basavarajappa HD, Corson TW: KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics? Future Med Chem 2012;4:2149-2152.
27. Corson TW, Huang A, Tsao MS, Gallie BL: KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005;24:4741-4753.
28. Kim TM, Yim SH, Shin SH, Xu HD, Jung YC, Park CK, Choi JY, Park WS, Kwon MS, Fiegler H, Carter NP, Rhyu MG, Chung YJ: Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer 2008;123:2808-2815.
29. Corson TW, Gallie BL: KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. Int J Cancer 2006;119:1088-1094.
30. Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL: KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res 2007;13:3229-3234.
31. Madhavan J, Coral K, Mallikarjuna K, Corson TW, Amit N, Khetan V, George R, Biswas J, Gallie BL, Kumaramanickavel G: High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Invest Ophthalmol Vis Sci 2007;48:4901-4906.
32. Theriault BL, Pajovic S, Bernardini MQ, Shaw PA, Gallie BL: Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer. Int J Cancer 2012;130:1844-1854.
33. Yang T, Zhang XB, Zheng ZM: Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome. Cancer Sci 2013;104:552-557.
34. Singel SM, Cornelius C, Zaganjor E, Batten K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, Wright WE, Lum L, Corson TW, Shay JW: KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia 2014;16:247-256.